Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia
- PMID: 238679
Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia
Similar articles
-
Bone-marrow transplantation in combined immunodeficiency disease.Boll Ist Sieroter Milan. 1974;53(1):suppl:245-58. Boll Ist Sieroter Milan. 1974. PMID: 4152798 No abstract available.
-
Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.Transplant Proc. 1976 Dec;8(4):623-8. Transplant Proc. 1976. PMID: 11594 No abstract available.
-
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.Transplant Proc. 1976 Dec;8(4):581-9. Transplant Proc. 1976. PMID: 63170 Review. No abstract available.
-
Discussion of bone marrow transplant: a correction for immunodeficiency diseases.Birth Defects Orig Artic Ser. 1975;11(1):425. Birth Defects Orig Artic Ser. 1975. PMID: 238686 No abstract available.
-
Cellular engineering.Clin Bull. 1977;7(1):33-9. Clin Bull. 1977. PMID: 359190 Review. No abstract available.
Cited by
-
Bone marrow transplantation for severe combined immunodeficiency disease. Reported from 1968 to 1977.Eur J Pediatr. 1979 Jun 28;131(3):155-77. doi: 10.1007/BF00538940. Eur J Pediatr. 1979. PMID: 38963